Role of blood Krebs von Lungen-6 in predicting acute exacerbation in patients with idiopathic pulmonary fibrosis.

Show other versions (1)

<h4>Background</h4>This study evaluated the role of blood Krebs von den Lungen-6 (KL-6) in predicting acute exacerbation (AE) in patients with idiopathic pulmonary fibrosis (IPF).<h4>Methods</h4>From April 2018 to March 2023, clinical data of 233 IPF patients with baseline an...

Full description

Bibliographic Details
Published in:	PLoS ONE
Main Authors:	Eun Jun Choe, Ji Hoon Jang, Jin Han Park, So Young Jung, Minyoung Her, Jae Ha Lee
Format:	Article
Language:	English
Published:	Public Library of Science (PLoS) 2025-01-01
Online Access:	https://doi.org/10.1371/journal.pone.0323784

Similar Items

Role of blood Krebs von Lungen-6 in predicting acute exacerbation in patients with idiopathic pulmonary fibrosis
by: Eun Jun Choe, et al.
Published: (2025-01-01)

Blood Krebs von den Lungen-6 levels predict treatment response to antifibrotic therapy in patients with idiopathic pulmonary fibrosis
by: Myeong Geun Choi, et al.
Published: (2022-12-01)

Role of BAL and Serum Krebs von den Lungen-6 (KL-6) in Patients with Pulmonary Fibrosis
by: Piera Soccio, et al.
Published: (2024-01-01)

Elevated Serum Level of Krebs von den Lungen-6 Predicts Death in Patients With Comorbid Idiopathic Pulmonary Fibrosis and Obstructive Sleep Apnea
by: Li F, et al.
Published: (2025-05-01)

Significance of serum Krebs von den Lungen-6 in systemic sclerosis
by: Noha Hosni Ibrahim, et al.
Published: (2023-11-01)

Krebs von den Lungen-6 surveillance in immune checkpoint inhibitor-induced pneumonitis
by: Isamu Okamoto, et al.
Published: (2024-12-01)

Serum concentrations of Krebs von den Lungen-6 as prognostic biomarker in patients with silicosis
by: Raluca-Andreea Smărăndescu, et al.
Published: (2025-06-01)

Comparative study between corticosteroids and colchicine effect on interleukin-6 and Krebs-von-den Lungen-6 in treatment of post covid pulmonary fibrosis
by: Mohamed A. E. G. Bedir, et al.
Published: (2024-07-01)

Correction: Serum concentrations of Krebs von den Lungen-6 as prognostic biomarker in patients with silicosis
by: Raluca-Andreea Smǎrǎndescu, et al.
Published: (2025-07-01)

A case of pleural mesothelioma with immunohistochemical staining positive for Krebs von den Lungen-6
by: Yugo Matsumura, et al.
Published: (2024-01-01)

Exploring the Role of Krebs von den Lungen-6 in Severe to Critical COVID-19 Patients
by: Vito D’Agnano, et al.
Published: (2022-07-01)

Novel Usefulness of Krebs von den Lungen 6 (KL-6) with Hemoglobin and Lactate Dehydrogenase for Assessing Bone Marrow Fibrosis
by: Minjeong Nam, et al.
Published: (2022-03-01)

Initial and peak serum levels of Krebs von den Lungen-6 for predicting the prognosis of patients with COVID-19
by: Geonui Kim, et al.
Published: (2025-03-01)

Diagnostic value of Krebs von den Lungen-6, a serological biomarker in interstitial lung disease
by: Cherukumalli Navya, et al.
Published: (2024-12-01)

Distribution of Presepsin, Krebs von den Lungen 6, and Surfactant Protein A in Umbilical Cord Blood
by: Minjeong Nam, et al.
Published: (2022-09-01)

Serum Krebs von den Lungen-6 as a potential biomarker for distinguishing combined pulmonary fibrosis and emphysema from chronic obstructive pulmonary disease: A retrospective study
by: Aiyuan Zhou, et al.
Published: (2024-08-01)

An in-depth investigation of serum Krebs von den Lungen-6 and other biomarkers in COVID-19 severity and mortality
by: Andro Pramana Witarto, et al.
Published: (2024-07-01)

Krebs von den Lungen 6 (KL-6) levels in COVID-19 ICU patients are associated with mortality
by: Giuliana Scarpati, et al.
Published: (2022-08-01)

Serum Krebs von den Lungen-6 as a potential biomarker for early diagnosis of silicosis: a case-control study
by: Qiying Nong, et al.
Published: (2025-08-01)

Efficacy of Pirfenidone According to Dose in Patients with Idiopathic Pulmonary Fibrosis: A Prospective, Observational, Single-Center Cohort Study
by: Ho Young Lee, et al.
Published: (2023-10-01)

Krebs von den Lungen-6 associated with chest high-resolution CT score in evaluation severity of patients with interstitial lung disease
by: H. Qin, et al.
Published: (2019-05-01)

Krebs von den Lungen-6 associated with chest high-resolution CT score in evaluation severity of patients with interstitial lung disease
by: H. Qin, et al.
Published: (2019-05-01)

Circulatory Serum Krebs von Den Lungen-6 and Surfactant Protein-D Concentrations Predict Interstitial Lung Disease Progression and Mortality
by: Meghna Rai, et al.
Published: (2023-04-01)

Clinical Relevance of the Serial Measurement of Krebs von den Lungen-6 Levels in Patients with Systemic Sclerosis-Associated Interstitial Lung Disease
by: Yuichiro Shirai, et al.
Published: (2021-10-01)

The Efficacy of Pulmonary Rehabilitation in Patients with Idiopathic Pulmonary Fibrosis
by: Hee Eun Choi, et al.
Published: (2023-02-01)

Serum Krebs von den Lungen-6 for Predicting the Severity of COVID-19: A Systematic Review, Meta-Analysis, and Trial Sequence Analysis
by: Abhigan Babu Shrestha, et al.
Published: (2023-01-01)

Serum Krebs von den Lungen-6 before treatment predicts the prognosis of lung cancer in Asian populations: a systematic review and meta-analysis
by: Hong Huang, et al.
Published: (2025-09-01)

The Role of SARS-CoV-2 Nucleocapsidic Antigen and Krebs von den Lungen 6 Serum Levels in Predicting COVID-19 Pneumonia Outcome
by: Stefano Sanduzzi Zamparelli, et al.
Published: (2024-03-01)

Krebs von den Lungen-6 glycoprotein circulating levels are not useful as prognostic marker in COVID-19 pneumonia: A large prospective cohort study
by: Ivan Castellví, et al.
Published: (2022-08-01)

Serum carbohydrate antigen 153 as a predictor of interstitial lung disease associated with rheumatoid arthritis is positively correlated with serum Krebs von den Lungen-6
by: Jiaxi Guo, et al.
Published: (2025-03-01)

Krebs von den Lungen 6 (KL-6) as a marker for disease severity and persistent radiological abnormalities following COVID-19 infection at 12 weeks.
by: David T Arnold, et al.
Published: (2021-01-01)

Direct hemoperfusion with polymyxin B-immobilized fiber column in a patient with acute exacerbation of idiopathic pulmonary fibrosis
by: Shin Young Kim, et al.
Published: (2020-11-01)

A nomogram model combining computed tomography-based radiomics and Krebs von den Lungen-6 for identifying low-risk rheumatoid arthritis-associated interstitial lung disease
by: Nie Han, et al.
Published: (2024-08-01)

Serum concentrations of Krebs von den Lungen-6, surfactant protein D, and matrix metalloproteinase-2 as diagnostic biomarkers in patients with asbestosis and silicosis: a case–control study
by: Changjiang Xue, et al.
Published: (2017-11-01)

Acute Exacerbation of Idiopathic Pulmonary Fibrosis
by: Lee Fidler, et al.
Published: (2015-01-01)

Acute Exacerbation of Idiopathic Pulmonary Fibrosis
by: Tomoo Kishaba
Published: (2019-03-01)

Efficacy of human epididymis protein-IV as potential lung disease biomarker in comparison to Krebs von den Lungen-VI glycoprotein and apoprotein A2 among systemic sclerosis patients
by: Alaa Mohammad El-Salawy, et al.
Published: (2024-11-01)

Elevated plasma levels of Krebs von den Lungen-6 and geographic appearance on high-resolution computed tomography are associated with diffuse alveolar damage in autopsy cases of acute respiratory distress syndrome: a retrospective study
by: Ryosuke Imai, et al.
Published: (2022-08-01)

Asymmetry in acute exacerbation of idiopathic pulmonary fibrosis
by: Akihiko Sokai, et al.
Published: (2017-04-01)

Combined pulmonary fibrosis and emphysema and idiopathic pulmonary fibrosis in non-small cell lung cancer: impact on survival and acute exacerbation
by: Sung Woo Moon, et al.
Published: (2019-10-01)